The Ultimate Guide to NAD+: What It Is and Why It Matters

NAD⁺ is the most heavily marketed idea in longevity supplements, and the one where the gap between the biology and the claims is widest.

This guide covers the whole category — NMN, nicotinamide riboside, niacin, NR-related forms and the products selling NAD⁺ itself — and sets out what each has actually been shown to do in humans, rather than in mice or in a dish.

For where NAD⁺ precursors rank against everything else, see our longevity supplements guide, and the longevity stack guide for where they belong in a routine.

For the compound-specific detail: NMN benefits, side effects and dosage, the NMN supplements range, NMN Pro 1000, and the wider anti-ageing and longevity supplements collection.

What NAD⁺ actually is

Nicotinamide adenine dinucleotide is a coenzyme present in every living cell. It exists in two interconverting forms — NAD⁺ (oxidised) and NADH (reduced) — and shuttles between them constantly as part of normal metabolism.

Its two headline roles:

• Energy metabolism. NAD⁺ is a central electron carrier in glycolysis, the citric acid cycle and oxidative phosphorylation. Without it, cells cannot convert food into usable energy.
• Enzymatic cofactor. NAD⁺ is consumed by sirtuins and PARPs — enzyme families involved in DNA repair, gene regulation and stress responses. Unlike its metabolic role, this one uses up NAD⁺, which is why supply matters.

None of that is contested. It is textbook biochemistry, and it is the reason the category exists at all.

Where the precursors fit

Your body makes NAD⁺ through several routes: de novo from tryptophan, and by salvage from precursors including nicotinamide, nicotinic acid, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Supplements target the salvage pathway, supplying a precursor and letting your cells finish the job.

The decline argument, examined

Every NAD⁺ product page rests on the same premise: NAD⁺ levels fall with age, so restoring them should restore function.

The first half is reasonably well supported. Tissue NAD⁺ concentrations do appear to decline with age across multiple species and tissue types.

The three things that premise does not establish

1. That the decline causes ageing rather than resulting from it. Declining NAD⁺ may be a consequence of increased consumption by PARPs responding to accumulated DNA damage — in which case raising supply treats a symptom.
2. That raising blood NAD⁺ raises it where it matters. Plasma is measurable; the tissues you care about mostly are not.
3. That restoring a youthful level restores youthful function. This is the assumption the whole category rests on and the one with the least direct evidence.

NMN: what the trials show

The positive findings

• Physical function and drowsiness. A randomised, double-blind, placebo-controlled study of 108 older Japanese adults gave 250 mg/day for 12 weeks, split by morning and afternoon dosing. Afternoon dosing was associated with improved five-times sit-to-stand performance and reduced drowsiness, with effect sizes of d = 0.72 and d = 0.64 [1].
• NAD⁺, walking speed and sleep. A 12-week randomised placebo-controlled trial found 250 mg/day raised blood NAD levels, helped maintain walking speed and improved sleep quality in older adults [2].

The negative findings

A systematic review and meta-analysis of eight randomised controlled trials — doses from 250 mg to 2,000 mg/day, durations from 14 days to 12 weeks, 342 middle-aged and older adults — found no significant benefit on fasting glucose, fasting insulin, HbA1c, insulin resistance or lipid profile [3]. A second meta-analysis reached the same conclusion on glucose and lipid metabolism [4].

So the honest summary: NAD⁺ elevation is consistent, the physical function and sleep signals are real but modest and from a small number of trials, and the metabolic claims are not supported.

Regulatory position

EFSA has issued a positive safety opinion on NMN, considering a daily intake of 300 mg safe for the general population excluding pregnant and lactating women [11]. Note the figure: 300 mg — much closer to the studied dose than to what most products supply.

Nicotinamide riboside: the better-regulated rival

NR is the other major precursor, and its trial base is arguably more mature than NMN's.

• A randomised, double-blind, placebo-controlled crossover trial in healthy middle-aged and older adults found chronic NR supplementation was well tolerated and effectively stimulated NAD⁺ metabolism [5].
• A trial in older men found NR supplementation raised NAD⁺ in blood but produced limited effect on skeletal muscle mitochondrial bioenergetics and inflammatory markers [6].
• A meta-analysis of NAD⁺ precursors and skeletal muscle found no significant changes in gait speed or skeletal muscle index [7].
• A randomised placebo-controlled trial in heart failure patients found NR was safe and raised whole-blood NAD⁺ [8].

The pattern is the same as NMN's: the biomarker moves reliably, the outcomes do not follow consistently.

NR versus NMN

NR completed European novel food authorisation earlier than NMN, which is a regulatory difference rather than an efficacy one. Head-to-head human outcome data is limited, and much comparative content online is published by companies selling one or the other — including some of the product-testing analyses. We cover this in Tru Niagen vs NMN.

Niacin and the cheap alternatives

Worth knowing before you spend: nicotinamide and nicotinic acid — ordinary vitamin B3 — are also NAD⁺ precursors, and they cost a fraction of NMN or NR.

They are not identical. Nicotinic acid causes flushing at higher doses, nicotinamide does not raise NAD⁺ through the same route as efficiently in some tissues, and neither has been marketed with the same claims. But anyone arguing that NAD⁺ elevation is the mechanism should be able to explain why the cheap precursors are dismissed.

The honest answer is that NMN and NR appear more efficient at raising NAD⁺ at tolerable doses, and have the trial base attached to them. But if the outcome data remains as thin as it currently is, the cost differential becomes harder to justify. See the Welzo vitamin B range.

Why "NAD⁺ supplements" are a chemistry problem

Some products sell NAD⁺ as the molecule rather than a precursor. This is worth understanding because it is the clearest instance in the category of a product that cannot work as described.

NAD⁺ is a large, charged, unstable dinucleotide. It is broken down in the digestive tract rather than absorbed intact, which is precisely why the research uses precursors. If a label sells you NAD⁺ in a capsule, the question to ask is what evidence exists that it reaches your cells in that form.

Sublingual and liposomal NAD⁺ products make delivery arguments to address this. The honest position is that improving a blood level is not the same as improving an outcome, and no enhanced-delivery NAD⁺ product has demonstrated better clinical results in humans. See sublingual NMN and liposomal NMN.

The surrogate marker problem

This is the intellectual crux of the whole category, and it deserves stating plainly.

"Raises NAD⁺" is a surrogate marker — a laboratory measurement standing in for a health outcome rather than being one.

Medicine has a long and expensive history with surrogate markers. Drugs that improved the number without improving the patient are common enough that regulators are now cautious about approving on that basis alone. NAD⁺ elevation is a plausible surrogate with a coherent mechanism behind it. But "this raises a molecule associated with youth" and "this makes you healthier for longer" are separated by exactly the evidence gap this guide is about.

Dose: the number the market ignores

Here is a fact that sits awkwardly with how NMN is sold, including by us.

The two trials producing the most encouraging functional results — improved sit-to-stand, reduced drowsiness, maintained walking speed, improved sleep quality — both used 250 mg per day [1,2]. Not 500 mg. Not 1,000 mg. Not 2,000 mg.

The market has drifted upward because a higher number sells better. But the meta-analysis covering 250 mg to 2,000 mg found no metabolic benefit across that entire range [3] — not the pattern you would expect if more were straightforwardly better. And EFSA's safety assessment was conducted at 300 mg/day [11].

We sell a 1,000 mg product. We would rather tell you the trials used 250 mg than have you find out elsewhere and wonder what else we left out. Dosing at 250–500 mg is defensible on the evidence and considerably cheaper — see NMN dosage by age and how much a longevity stack costs.

What is actually in the bottle

Researchers at the National University of Singapore tested commercial NMN supplements against their label claims. Measured content deviated from label claim by between −100% and +11.2% — several products contained no detectable NMN whatsoever [9,10].

That finding reframes every debate about NMN versus NR versus dose. If a meaningful share of products contain nothing, the experience of "NMN did nothing for me" may have nothing to do with NMN.

The defence is a batch-specific certificate of analysis for the finished product, from a named independent laboratory, with a lot number matching your bottle. The COA for NMN Pro 1000 is published on its product page — open it, and apply the same demand to every competitor. See how to read a certificate of analysis and third-party testing: what it means and what it doesn't.

Do you need TMG alongside?

NAD⁺ precursors are metabolised through pathways that consume methyl groups, which is the basis for pairing them with trimethylglycine (TMG, betaine). Whether you personally need it depends on your diet and dose, and the argument is more contested than the bundling suggests.

We set out both sides in do I need TMG with NMN? and compare it with the alternative in TMG vs methylfolate. If you want them together, the NMN & TMG stack costs less than buying both separately.

Our verdict, and who should bother

We sell these products. Here is what we actually think:

• The category is not a scam, but it is oversold. The biochemistry is real, NAD⁺ elevation is real, and the human outcome data is early, mixed and modest.
• It belongs late in a stack. Vitamin D [12], omega-3, magnesium and creatine [13] all have stronger evidence per pound spent.
• Product verification matters more than precursor choice. Given that testing has found products with no detectable active [9,10], the COA is not optional.
• The dose evidence points lower than the market does [1,2,11].
• Judge it properly if you try it. Twelve weeks minimum, track something specific, and be willing to conclude it did nothing — see how long supplements take to work and what happens when you stop taking NMN.

Who might reasonably take one

• Older adults interested in the physical function and sleep signals, dosing at 250–500 mg [1,2].
• People who have already covered the foundations and understand they are buying an open question.

Who should skip it

• Anyone yet to cover vitamin D, omega-3, magnesium and creatine [12,13] — see the minimal supplement stack and the cheap longevity stack.
• Anyone on a constrained budget — this is among the most expensive and least certain combinations available.
• Anyone expecting something dramatic. The measured effects were modest and instrument-detected.
• Anyone pregnant or breastfeeding — EFSA's safety opinion explicitly excluded these groups [11].

Deeper reading: is NMN a scam?, urolithin A vs NMN, NMN vs creatine, when to take NMN, NMN with food, cycling NMN and where to buy NMN in the UK.

When to speak to a doctor

Speak to your GP or pharmacist before starting any NAD⁺ precursor if you take prescription medication, have an existing medical condition — particularly liver or kidney disease — or are pregnant, breastfeeding or trying to conceive. These are not suitable during pregnancy or breastfeeding, or for children.

If your reason for considering them is fatigue, low energy or brain fog, get those investigated before buying anything. Iron deficiency, thyroid dysfunction, sleep apnoea, depression and B12 deficiency are all common, all treatable, and none respond to NAD⁺ precursors. A tiredness and fatigue blood test, thyroid blood test, ferritin blood test or Full Body MOT Health Check is a better first purchase.

Frequently asked questions

What is the best NAD⁺ supplement?

NMN and nicotinamide riboside both reliably raise blood NAD⁺ in humans [1,2,5]. Neither has demonstrated consistent downstream benefit — an NMN meta-analysis of eight RCTs found no metabolic effect [3,4], and NR trials show reliable NAD⁺ elevation with limited functional change [6,7]. Choose on verified product quality and cost per studied dose rather than on precursor type.

Does NMN or NR work better?

There is little head-to-head human outcome data, and much comparative content is published by companies selling one or the other. NR completed European novel food authorisation earlier, which is regulatory rather than an efficacy difference. See Tru Niagen vs NMN.

Can you take NAD⁺ directly as a supplement?

Products exist, but NAD⁺ is a large, unstable molecule broken down in the digestive tract rather than absorbed intact — which is exactly why research uses precursors like NMN and NR. If a label sells NAD⁺ directly, ask what evidence exists that it reaches your cells in that form.

How much NMN should I take?

The trials producing the most encouraging functional results used 250 mg per day [1,2], and EFSA assessed 300 mg/day as safe for the general population [11]. Doses up to 2,000 mg have been used without serious adverse events, but the meta-analysis found no benefit across that whole range [3]. Starting at 250–500 mg is defensible and cheaper.

Does raising NAD⁺ actually make you healthier?

That is the open question. NAD⁺ elevation is a surrogate marker — a laboratory measurement standing in for a health outcome. Medicine has repeatedly found interventions that moved a marker without helping the patient. The NMN meta-analyses are exactly that pattern: NAD⁺ up, metabolic markers unchanged [3,4].

Why do some people say NMN did nothing for them?

Three plausible reasons. The product may not have contained meaningful NMN — independent testing found deviation from label claim between −100% and +11.2%, with several products empty [9,10]. The measured effects in trials were modest and instrument-detected rather than something you would feel. Or it may genuinely do little for that person, particularly if younger and healthy, since most positive trials were in older adults.

Is niacin a cheaper alternative?

Nicotinamide and nicotinic acid are also NAD⁺ precursors and cost far less. They are not equivalent — efficiency of NAD⁺ elevation differs, nicotinic acid causes flushing at higher doses, and the trial base is attached to NMN and NR rather than to them. But anyone arguing NAD⁺ elevation is the whole mechanism should be able to explain why the cheap precursors are dismissed.

Do I need TMG with NMN?

It depends on your diet and dose, and the argument is more contested than the bundling implies. NAD⁺ precursors are metabolised through methyl-consuming pathways, which is the rationale. We set out both sides in do I need TMG with NMN?

How do I know my NMN is real?

Ask for a batch-specific certificate of analysis from a named independent laboratory and check the lot number matches your bottle. "Lab tested" without a document you can open means nothing. Given that independent research found commercial products with no detectable NMN [9,10], this is the single most important check.

Should I take an NAD⁺ precursor in my 30s?

The positive trials were conducted in older adults, typically 60 and above [1,2]. There is very little evidence in younger, healthy populations, and the theoretical rationale — restoring an age-related decline — is weakest in people who have not experienced much of that decline. See longevity supplements in your 30s.

References

1. Kim M, Seol J, Sato T, et al. Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults. Nutrients. 2022;14(4):755. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877443/
2. Morifuji M, Higashi S, Ebihara S, Nagata M. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults. GeroScience. 2024;46(5):4671–4688. https://pmc.ncbi.nlm.nih.gov/articles/PMC11336149/
3. Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Current Diabetes Reports. 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557618/
4. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Critical Reviews in Food Science and Nutrition. 2024. https://www.tandfonline.com/doi/full/10.1080/10408398.2024.2387324
5. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD⁺ in healthy middle-aged and older adults. Nature Communications. 2018;9:1286. https://www.nature.com/articles/s41467-018-03421-7
6. Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD⁺ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports. 2019;28(7):1717–1728. https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30940-9
7. The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC12022230/
8. Airhart SE, Shireman LM, Risler LJ, et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD⁺ levels in healthy volunteers. PLOS One. 2017;12(12):e0186459. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186459
9. NUS Medicine. Significant discrepancies between actual and labelled amount of anti-ageing ingredients in supplements. National University of Singapore, 2024. https://medicine.nus.edu.sg/news/significant-discrepancies-between-actual-and-labelled-amount-of-anti-ageing-ingredients-in-supplements-nus-medicine-study/
10. Sandalova E, et al. Testing the amount of nicotinamide mononucleotide and urolithin A as compared to the label claim. GeroScience. 2024;46:5075–5083. Reported in NutraIngredients: https://www.nutraingredients.com/Article/2024/08/23/Many-NMN-and-Urolithin-A-supplements-failing-to-match-label-claims/
11. NutraIngredients. EFSA gives positive safety opinion on NMN. 2026. https://www.nutraingredients.com/Article/2026/05/13/efsa-gives-positive-safety-opinion-on-nmn/
12. NHS. Vitamin D — Vitamins and minerals. https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/
13. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition. 2017;14:18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469049/
14. Semba RD, Ferrucci L, Bartali B, et al. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Internal Medicine. 2014;174(7):1077–1084. https://pubmed.ncbi.nlm.nih.gov/24819981/
15. Liu S, D'Amico D, Shankland E, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Network Open. 2022;5(1):e2144279. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2788244

All product photography in this article is owned by Welzo and served from the Welzo media library. Prices and regulatory positions correct at the time of publication and subject to change.